Bruker Corporation
BRKR
$57.71
$0.040.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.50B | 3.46B | 3.44B | 3.44B | 3.44B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.50B | 3.46B | 3.44B | 3.44B | 3.44B |
| Cost of Revenue | 1.81B | 1.82B | 1.79B | 1.76B | 1.76B |
| Gross Profit | 1.69B | 1.64B | 1.64B | 1.67B | 1.69B |
| SG&A Expenses | 967.80M | 960.30M | 944.10M | 945.90M | 933.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.50M | 24.90M | 27.30M | -31.00M | 10.50M |
| Total Operating Expenses | 3.19B | 3.20B | 3.16B | 3.08B | 3.10B |
| Operating Income | 309.50M | 256.70M | 275.80M | 359.30M | 343.20M |
| Income Before Tax | -24.10M | 13.70M | 21.00M | 8.60M | 136.30M |
| Income Tax Expenses | 40.40M | 23.10M | 29.30M | 32.20M | 61.10M |
| Earnings from Continuing Operations | -64.50 | -9.40 | -8.30 | -23.60 | 75.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.70M | -2.20M | -300.00K | 2.70M | 4.40M |
| Net Income | -71.20M | -11.60M | -8.60M | -20.90M | 79.60M |
| EBIT | 309.50M | 256.70M | 275.80M | 359.30M | 343.20M |
| EBITDA | 539.60M | 484.90M | 496.10M | 574.40M | 553.60M |
| EPS Basic | -0.70 | -0.24 | -0.15 | -0.16 | 0.53 |
| Normalized Basic EPS | 1.17 | 0.92 | 1.01 | 1.37 | 1.30 |
| EPS Diluted | -0.71 | -0.24 | -0.15 | -0.16 | 0.52 |
| Normalized Diluted EPS | 1.17 | 0.92 | 1.01 | 1.37 | 1.30 |
| Average Basic Shares Outstanding | 608.20M | 607.60M | 607.00M | 606.60M | 606.30M |
| Average Diluted Shares Outstanding | 609.30M | 608.70M | 607.90M | 607.40M | 607.60M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | -76.83% | -377.59% | -382.56% | -109.57% | 38.32% |